Navigation Links
Market for Select Cardiovascular Drugs in the GCC Region-2012-16
Date:9/24/2013

DUBLIN, September 24, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/xvj2zn/market_for_select) has announced the addition of the "Market for Select Cardiovascular Drugs in the GCC Region-2012-16" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The $7.6 bn Pharmaceutical industry in the GCC region is poised for major growth in the coming years. Increase in the international crude oil prices and exports of crude and petro products have transformed the GCC economy. The local governments are increasingly focusing on improving the health and living standards of the population. Contraints in local manufacturing capacity and thriving counterfeit drugs market pose a major challenge but improved regulatory mechanism, increase in private sector participation coupled with rising private and public sector outlay and spend on healthcare presents a promising future for the industry.

This report focuses on the market for select cardiovascular drugs in the GCC region. Various market drivers in terms of changing lifestyle and rising disease incidence among the population has led to higher consumption of cardiovascular drugs in the region. Sensing the latent market opportunity, global pharma majors such as Novartis, Abbott, AstraZeneca have set up operations in the GCC region through local joint venture and distribution.

In addition to market forecast to 2016, the report also provides interesting insights into key molecules used, top brands, drug prices, procurement process among government and retail institutions. The report will serve as an effective guide for the drug companies, distributors, hospitals and other stakeholders who wish to enter the GCC healthcare market. The report also has profiles of companies and distributors in the GCC region."

Key Topics Covered:

1. Methodology

2. Report Coverage

3. Glossary of terms

4. Executive summary

5. Healthcare sector in GCC

6. Pharmaceutical market in GCC

7. Cardiovascular market for select drugs in GCC

8. Profiles of key domestic pharmaceutical manufacturers

9. Annexure - Drugs price details by country - 2012

List of Exhibits

Companies Mentioned

- AstraZeneca
- Global Pharma
- Jamjoom Pharma
- Julphar - Gulf Pharmaceutical Industries
- Kuwait Saudi Pharmaceutical Industries
- Merck & Co., Inc
- National Pharmaceutical Industries Co
- Neo Pharma
- Novartis International AG
- Oman Pharmaceutical Products Co. L.L.C
- Pfizer, Inc
- Sanofi S.A.
- Saudi Pharmaceutical Industries & Medical Appliances Corporation
- Tabuk Pharmaceuticals Manufacturing Company

For more information visit http://www.researchandmarkets.com/research/xvj2zn/market_for_select

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Healthcare and Medical Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The US Ear, Nose And Throat And Bronchoscopy Device Markets Will Reach A Combined Value Exceeding $715 Million In 2021
2. Market for Local Anaesthesia in the GCC Region 2012-17
3. FDAs Plan & Congressional Take on Mobile Medical Apps Market
4. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
5. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
6. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
7. iConcept Launches GIS-Based CRM Tools to Reach Non-Captive Market
8. Cloud-Based Online Registration Platform Licensale.com Revolutionizes Medical Device Market
9. The US Market for Electronic Medical Records Will Decline Due to Market Saturation
10. Montmed to Launch DiaClin General & Diabetic Skin Care Product Line for Canadian Marketplace
11. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , February 10, 2016 ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market ... Technologies, Participants, and Environment" research report indicates that ... over $149 billion by 2020 growing at a ... of companion diagnostics and targeted therapeutics and is ...
(Date:2/9/2016)... CITY, Calif. , Feb. 9, 2016 /PRNewswire/ - ... device company that is providing innovative evidence-based solutions for ... will release financial results for the fourth quarter and ... February 29, 2016. Company management will host a conference ... Eastern Time) on Monday, February 29, 2016. ...
(Date:2/9/2016)... BILLERICA, Mass. , Feb. 9, 2016  Insulet Corporation ... in tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s ... comprised of nine directors, eight of whom are independent. ... over 40 years of audit and finance experience and a ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO ... new 2.0 version at the International Roofing Expo in Orlando, Florida on February ... world's most advanced weather technology in the hands of consumers, roofing contractors, manufacturers ...
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... Tucson, AZ (PRWEB) , ... February 10, 2016 , ... ... prompted the Aging Life Care Association™ (ALCA) to conduct a survey that takes a ... aging experts released today illustrates the prevalence and causes of TBI among the aging ...
(Date:2/10/2016)... ... 10, 2016 , ... Armune BioScience signed a definitive agreement with ... service centers across the country. Launched in April of 2015, Apifiny is the only ... cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Club ... awarded the prestigious Distinguished Emerald Club of the World award, as determined by ... one of the most respected trade publications serving private clubs. , “We’d like ...
Breaking Medicine News(10 mins):